MOG-A

Business Context and Reporting Period

Company: Moog Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: September 30, 2006 (53-week fiscal year)
Business Overview: Moog is a global designer and manufacturer of high-performance precision motion and fluid controls for aerospace, defense, industrial, and medical markets. The company operates through five segments: Aircraft Controls, Space and Defense Controls, Industrial Controls, Components, and Medical Devices (established in 2006 via acquisitions).

Key Financial Metrics

Debt & Liquidity: Total debt to capitalization was 33.6% in 2006 (down from 40.1% in 2005). The company maintains a $600 million revolving credit facility with $484 million in unused capacity as of October 2006. Working capital increased to $420.5 million.

Material Changes vs. Prior Period

• Revenue Growth: Sales increased by $255 million (24%). Approximately half of this growth was attributed to acquisitions (Curlin Medical, McKinley Medical, Flo-Tork, and Kaydon Power & Data Technologies). Organic growth occurred across all existing segments.
• Acquisitions: The company formed a new "Medical Devices" segment in 2006 following the acquisitions of Curlin Medical ($77 million) and McKinley Medical ($15 million). These acquisitions contributed to the increase in goodwill, which rose to $451 million.
• Research & Development: R&D expenses surged to $69 million (from $44 million in 2005), primarily driven by development work on the Boeing 787 Dreamliner ($31 million in 2006).
• Stock Issuance: In February 2006, the company sold 2.875 million shares of Class A common stock for net proceeds of $84 million, used to pay down debt and fund acquisitions.
• Cash Flow: Operating cash flow decreased by $30 million, primarily due to higher working capital requirements (inventory buildup) associated with increased sales volume.

Guidance, Outlook, and Risks

2007 Outlook

• Sales: Expected to increase 9% to 11% to a range of $1.428 billion to $1.448 billion.
• Operating Margin: Expected to be 12.6% (up from 12.4% in 2006).
• Net Earnings: Expected to range between $94 million and $98 million.
• Diluted EPS: Expected to range between $2.21 and $2.29 (12% to 16% increase).

Key Risks and Contingencies

• Government Contracts: 33% of sales are derived from U.S. Government contracts, which are subject to funding changes, termination, and regulatory compliance risks.
• Customer Concentration: Boeing and Lockheed Martin each represented approximately 9% of 2006 sales. Loss of either customer would significantly impact earnings.
• Accounting Estimates: 34% of sales are recognized using the percentage-of-completion method. Changes in cost estimates on long-term contracts can materially affect earnings.
• Goodwill Impairment: Goodwill represents 28% of total assets ($451 million). Impairment charges could reduce net worth and potentially violate debt covenants.
• Unresolved SEC Comments: The company is in ongoing correspondence with the SEC staff regarding the determination of reportable segments and reporting units for goodwill impairment testing.

Investor Verification Checklist

• Acquisition Integration: Verify the performance of the new Medical Devices segment and the integration of recent acquisitions (Curlin, McKinley, Flo-Tork) against the projected synergies.
• Boeing 787 Program: Monitor the transition of the Boeing 787 program from development to production to assess the impact on R&D expenses and future margins in the Aircraft Controls segment.
• Government Funding: Track U.S. defense budget allocations and the status of key programs (F-35, V-22 Osprey) given the high reliance on government contracts.
• Working Capital Management: Review inventory levels and receivables aging to ensure the 2006 cash flow decline was a temporary working capital buildup rather than a structural issue.
• Debt Covenants: Confirm continued compliance with the minimum net worth and leverage ratio covenants in the $600 million credit facility, especially given the high level of goodwill.